Pharmacoeconomics; an appropriate tool for policy makers or just a new field of research in iran?
作者信息
Davari Majid
机构信息
Health Management and Economics Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
出版信息
Iran J Pharm Res. 2012 Winter;11(1):1-2.
Abstract
摘要
相似文献
1
Pharmacoeconomics; an appropriate tool for policy makers or just a new field of research in iran?药物经济学：是政策制定者的合适工具还是伊朗一个新的研究领域？
Iran J Pharm Res. 2012 Winter;11(1):1-2.
2
Decision-makers' use of pharmacoeconomics: what does the research tell us?决策者对药物经济学的使用：研究告诉了我们什么？
Expert Rev Pharmacoecon Outcomes Res. 2001 Dec;1(2):133-44. doi: 10.1586/14737167.1.2.133.
3
The role of pharmacoeconomics in current Indian healthcare system.药物经济学在当前印度医疗保健系统中的作用。
J Res Pharm Pract. 2013 Jan;2(1):3-9. doi: 10.4103/2279-042X.114081.
4
Do economic evaluation studies inform effective healthcare resource allocation in Iran? A critical review of the literature.经济评估研究是否为伊朗有效的医疗资源分配提供了信息？文献综述。
Cost Eff Resour Alloc. 2014 Jul 11;12:15. doi: 10.1186/1478-7547-12-15. eCollection 2014.
5
National policy-makers speak out: are researchers giving them what they need?国家政策制定者发声：研究人员是否提供了他们所需的信息？
Health Policy Plan. 2011 Jan;26(1):73-82. doi: 10.1093/heapol/czq020. Epub 2010 Jun 14.
6
Pharmacoeconomics and immunotherapy.药物经济学与免疫疗法
Eur Ann Allergy Clin Immunol. 2007;39 Spec No:12-6.
7
Pharmacoeconomics in oncology.肿瘤药理学。
Expert Rev Pharmacoecon Outcomes Res. 2002 Jun;2(3):251-60. doi: 10.1586/14737167.2.3.251.
8
Barriers to implementing pharmacoeconomics: interview study.实施药物经济学的障碍：访谈研究。
Expert Rev Pharmacoecon Outcomes Res. 2021 Feb;21(1):93-104. doi: 10.1080/14737167.2020.1766969. Epub 2020 May 29.
9
Human embryonic stem cell science and policy: the case of Iran.人类胚胎干细胞科学与政策：以伊朗为例。
Soc Sci Med. 2013 Dec;98(100):345-50. doi: 10.1016/j.socscimed.2013.10.028. Epub 2013 Nov 1.
10
Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services.
Hosp Formul. 1993 Apr;28(4):365-6, 371-3, 377-8.
引用本文的文献
1
Measuring Equity in Access to Pharmaceutical Services Using Concentration Curve; Model Development.使用集中度曲线衡量药品服务可及性的公平性；模型开发。
Iran J Pharm Res. 2015 Fall;14(4):1317-26.
2
Costs of Treatment after Renal Transplantation: Is it Worth to Pay More?肾移植后的治疗费用：多花钱是否值得？
Iran J Pharm Res. 2014 Winter;13(1):271-8.
3
Decentralization and hospital pharmacy services: the case of Iranian university affilliated hospitals.权力下放与医院药学服务：以伊朗大学附属医院为例
Iran J Pharm Res. 2013 Winter;12(Suppl):183-8.
Zotero 插件